You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
McKesson
Colorcon
Baxter
Dow

Last Updated: April 20, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NALTREXONE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Naltrexone Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000195 Neurobiology of Opioid Dependence: 4 - 4 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 1993-01-01 The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.
NCT00000195 Neurobiology of Opioid Dependence: 4 - 4 Withdrawn Yale University Phase 2 1993-01-01 The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.
NCT00000196 Neurobiology of Opioid Dependence: 5 - 5 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 1993-01-01 The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.
NCT00000196 Neurobiology of Opioid Dependence: 5 - 5 Withdrawn Yale University Phase 2 1993-01-01 The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Naltrexone Hydrochloride

Condition Name

Condition Name for Naltrexone Hydrochloride
Intervention Trials
Alcoholism 53
Alcohol Dependence 49
Obesity 26
Opioid-Related Disorders 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Naltrexone Hydrochloride
Intervention Trials
Alcoholism 108
Opioid-Related Disorders 49
Disease 42
Substance-Related Disorders 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Naltrexone Hydrochloride

Trials by Country

Trials by Country for Naltrexone Hydrochloride
Location Trials
United States 697
Canada 14
Germany 13
China 12
Russian Federation 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Naltrexone Hydrochloride
Location Trials
New York 64
Connecticut 51
California 46
Pennsylvania 45
Texas 35
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Naltrexone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Naltrexone Hydrochloride
Clinical Trial Phase Trials
Phase 4 92
Phase 3 60
Phase 2/Phase 3 31
[disabled in preview] 127
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Naltrexone Hydrochloride
Clinical Trial Phase Trials
Completed 233
Not yet recruiting 70
Recruiting 62
[disabled in preview] 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Naltrexone Hydrochloride

Sponsor Name

Sponsor Name for Naltrexone Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 86
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 56
Yale University 36
[disabled in preview] 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Naltrexone Hydrochloride
Sponsor Trials
Other 432
NIH 160
Industry 105
[disabled in preview] 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKesson
Boehringer Ingelheim
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.